'Next Ozempic' aims to deliver 30% weight loss with fewer side effects Scientists have created a pre-clinical weight loss drug combining GLP-1, GIP, glucagon and peptide YY hormones to match bariatric surgery effectiveness. Original Source: https://www.foxnews.com/health/next-ozempic-aims-deliver-weight-loss-fewer-side-effects
